BitMine Chairman Tom Lee predicts Ethereum's price could surpass $10,000 within the next year, fueled by strong institutional demand, tokenization growth, and treasury accumulation by digital asset companies. BitMine itself has amassed over 6 million ETH, highlighting significant buying even during bear markets. Institutional investors are expected to increase crypto allocations, while tokenization on public blockchains like Ethereum offers new growth opportunities. This demand, combined with Ethereum's large developer base and security, could reduce supply and boost prices significantly in the current crypto cycle.
Ethereum price outlook is the subject, with Pluang market data providing context. As of Oct 20, 2026 08:21 WIB, 16 of 50 major cryptocurrencies rose, 33 fell. Cosmos (ATOM) traded at Rp31.379, up 2.88%, with 76% buy orders and a typical hold time of 61 days. Cardano (ADA) was at Rp3.886, down 2.53%, with 55% buy orders and a 127-day hold time. Curve DAO Token (CRV) stood at Rp6.589, up 2.38%, but had 99% sell orders and a 62-day hold time.
Anteris Technologies received regulatory approval from Germany's BfArM to start enrolling patients in its global PARADIGM trial for the DurAVR Transcatheter Heart Valve. This approval allows the company to recruit patients at leading German centers, ...
XBiotech announced positive final efficacy results from its phase II TASKIN trial for vilamakitug (XB2001) in refractory metastatic colorectal cancer. The study, funded by the French National Cancer Institute, showed a 61.3% overall survival rate at ...
XBiotech announced positive final results from the Phase II TASKIN study, showing that adding Vilamakitug (XB2001) to standard chemotherapy improved 12-month overall survival to 61.3% in patients with refractory metastatic colorectal cancer, surpassi...
Recce Pharmaceuticals has reached a key milestone in its Phase 3 trial for treating diabetic foot infections with its RECCE® 327 Gel (R327G). An independent Data Monitoring Committee will review unblinded data from 75 patients, following encouraging ...
Flipkart, owned by Walmart, is launching a food delivery service in India to compete against dominant players Zomato and Swiggy. The company is currently testing the service internally in Bengaluru with plans for a public launch by October and expans...
